Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Eye Drops for Glaucoma Market Growth 2022-2028

  • LP 4967918
  • 108 Pages
  • June 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Eye Drops for Glaucoma will have significant change from previous year. According to our (LP Information) latest study, the global Eye Drops for Glaucoma market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Eye Drops for Glaucoma market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Eye Drops for Glaucoma market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Eye Drops for Glaucoma market, reaching US$ million by the year 2028. As for the Europe Eye Drops for Glaucoma landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Eye Drops for Glaucoma players cover Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, and Zentiva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Eye Drops for Glaucoma market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Bimatoprost

Latanoprost

Tafluprost

Travoprost

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Ophthalmic Clinic

Pharmacy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Thea Pharmaceuticals Ltd

FDC International Ltd

Martindale Pharma

Zentiva

Upjohn UK Limited

Beacon Pharmaceuticals

Novartis Pharmaceuticals UK Ltd

Mylan

Accord Healthcare Limited

Sandoz Limited

Thornton & Ross Ltd

Aspire Pharma Ltd

AbbVie Ltd

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Eye Drops for Glaucoma Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Eye Drops for Glaucoma by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Eye Drops for Glaucoma by Country/Region, 2017, 2022 & 2028

2.2 Eye Drops for Glaucoma Segment by Type

2.2.1 Bimatoprost

2.2.2 Latanoprost

2.2.3 Tafluprost

2.2.4 Travoprost

2.3 Eye Drops for Glaucoma Sales by Type

2.3.1 Global Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)

2.3.2 Global Eye Drops for Glaucoma Revenue and Market Share by Type (2017-2022)

2.3.3 Global Eye Drops for Glaucoma Sale Price by Type (2017-2022)

2.4 Eye Drops for Glaucoma Segment by Application

2.4.1 Hospital

2.4.2 Ophthalmic Clinic

2.4.3 Pharmacy

2.4.4 Others

2.5 Eye Drops for Glaucoma Sales by Application

2.5.1 Global Eye Drops for Glaucoma Sale Market Share by Application (2017-2022)

2.5.2 Global Eye Drops for Glaucoma Revenue and Market Share by Application (2017-2022)

2.5.3 Global Eye Drops for Glaucoma Sale Price by Application (2017-2022)

3 Global Eye Drops for Glaucoma by Company

3.1 Global Eye Drops for Glaucoma Breakdown Data by Company

3.1.1 Global Eye Drops for Glaucoma Annual Sales by Company (2020-2022)

3.1.2 Global Eye Drops for Glaucoma Sales Market Share by Company (2020-2022)

3.2 Global Eye Drops for Glaucoma Annual Revenue by Company (2020-2022)

3.2.1 Global Eye Drops for Glaucoma Revenue by Company (2020-2022)

3.2.2 Global Eye Drops for Glaucoma Revenue Market Share by Company (2020-2022)

3.3 Global Eye Drops for Glaucoma Sale Price by Company

3.4 Key Manufacturers Eye Drops for Glaucoma Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Eye Drops for Glaucoma Product Location Distribution

3.4.2 Players Eye Drops for Glaucoma Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Eye Drops for Glaucoma by Geographic Region

4.1 World Historic Eye Drops for Glaucoma Market Size by Geographic Region (2017-2022)

4.1.1 Global Eye Drops for Glaucoma Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Eye Drops for Glaucoma Annual Revenue by Geographic Region

4.2 World Historic Eye Drops for Glaucoma Market Size by Country/Region (2017-2022)

4.2.1 Global Eye Drops for Glaucoma Annual Sales by Country/Region (2017-2022)

4.2.2 Global Eye Drops for Glaucoma Annual Revenue by Country/Region

4.3 Americas Eye Drops for Glaucoma Sales Growth

4.4 APAC Eye Drops for Glaucoma Sales Growth

4.5 Europe Eye Drops for Glaucoma Sales Growth

4.6 Middle East & Africa Eye Drops for Glaucoma Sales Growth

5 Americas

5.1 Americas Eye Drops for Glaucoma Sales by Country

5.1.1 Americas Eye Drops for Glaucoma Sales by Country (2017-2022)

5.1.2 Americas Eye Drops for Glaucoma Revenue by Country (2017-2022)

5.2 Americas Eye Drops for Glaucoma Sales by Type

5.3 Americas Eye Drops for Glaucoma Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Eye Drops for Glaucoma Sales by Region

6.1.1 APAC Eye Drops for Glaucoma Sales by Region (2017-2022)

6.1.2 APAC Eye Drops for Glaucoma Revenue by Region (2017-2022)

6.2 APAC Eye Drops for Glaucoma Sales by Type

6.3 APAC Eye Drops for Glaucoma Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Eye Drops for Glaucoma by Country

7.1.1 Europe Eye Drops for Glaucoma Sales by Country (2017-2022)

7.1.2 Europe Eye Drops for Glaucoma Revenue by Country (2017-2022)

7.2 Europe Eye Drops for Glaucoma Sales by Type

7.3 Europe Eye Drops for Glaucoma Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Eye Drops for Glaucoma by Country

8.1.1 Middle East & Africa Eye Drops for Glaucoma Sales by Country (2017-2022)

8.1.2 Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2017-2022)

8.2 Middle East & Africa Eye Drops for Glaucoma Sales by Type

8.3 Middle East & Africa Eye Drops for Glaucoma Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Eye Drops for Glaucoma

10.3 Manufacturing Process Analysis of Eye Drops for Glaucoma

10.4 Industry Chain Structure of Eye Drops for Glaucoma

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Eye Drops for Glaucoma Distributors

11.3 Eye Drops for Glaucoma Customer

12 World Forecast Review for Eye Drops for Glaucoma by Geographic Region

12.1 Global Eye Drops for Glaucoma Market Size Forecast by Region

12.1.1 Global Eye Drops for Glaucoma Forecast by Region (2023-2028)

12.1.2 Global Eye Drops for Glaucoma Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Eye Drops for Glaucoma Forecast by Type

12.7 Global Eye Drops for Glaucoma Forecast by Application

13 Key Players Analysis

13.1 Thea Pharmaceuticals Ltd

13.1.1 Thea Pharmaceuticals Ltd Company Information

13.1.2 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product Offered

13.1.3 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Thea Pharmaceuticals Ltd Main Business Overview

13.1.5 Thea Pharmaceuticals Ltd Latest Developments

13.2 FDC International Ltd

13.2.1 FDC International Ltd Company Information

13.2.2 FDC International Ltd Eye Drops for Glaucoma Product Offered

13.2.3 FDC International Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 FDC International Ltd Main Business Overview

13.2.5 FDC International Ltd Latest Developments

13.3 Martindale Pharma

13.3.1 Martindale Pharma Company Information

13.3.2 Martindale Pharma Eye Drops for Glaucoma Product Offered

13.3.3 Martindale Pharma Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Martindale Pharma Main Business Overview

13.3.5 Martindale Pharma Latest Developments

13.4 Zentiva

13.4.1 Zentiva Company Information

13.4.2 Zentiva Eye Drops for Glaucoma Product Offered

13.4.3 Zentiva Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Zentiva Main Business Overview

13.4.5 Zentiva Latest Developments

13.5 Upjohn UK Limited

13.5.1 Upjohn UK Limited Company Information

13.5.2 Upjohn UK Limited Eye Drops for Glaucoma Product Offered

13.5.3 Upjohn UK Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Upjohn UK Limited Main Business Overview

13.5.5 Upjohn UK Limited Latest Developments

13.6 Beacon Pharmaceuticals

13.6.1 Beacon Pharmaceuticals Company Information

13.6.2 Beacon Pharmaceuticals Eye Drops for Glaucoma Product Offered

13.6.3 Beacon Pharmaceuticals Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Beacon Pharmaceuticals Main Business Overview

13.6.5 Beacon Pharmaceuticals Latest Developments

13.7 Novartis Pharmaceuticals UK Ltd

13.7.1 Novartis Pharmaceuticals UK Ltd Company Information

13.7.2 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product Offered

13.7.3 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novartis Pharmaceuticals UK Ltd Main Business Overview

13.7.5 Novartis Pharmaceuticals UK Ltd Latest Developments

13.8 Mylan

13.8.1 Mylan Company Information

13.8.2 Mylan Eye Drops for Glaucoma Product Offered

13.8.3 Mylan Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mylan Main Business Overview

13.8.5 Mylan Latest Developments

13.9 Accord Healthcare Limited

13.9.1 Accord Healthcare Limited Company Information

13.9.2 Accord Healthcare Limited Eye Drops for Glaucoma Product Offered

13.9.3 Accord Healthcare Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Accord Healthcare Limited Main Business Overview

13.9.5 Accord Healthcare Limited Latest Developments

13.10 Sandoz Limited

13.10.1 Sandoz Limited Company Information

13.10.2 Sandoz Limited Eye Drops for Glaucoma Product Offered

13.10.3 Sandoz Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sandoz Limited Main Business Overview

13.10.5 Sandoz Limited Latest Developments

13.11 Thornton & Ross Ltd

13.11.1 Thornton & Ross Ltd Company Information

13.11.2 Thornton & Ross Ltd Eye Drops for Glaucoma Product Offered

13.11.3 Thornton & Ross Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Thornton & Ross Ltd Main Business Overview

13.11.5 Thornton & Ross Ltd Latest Developments

13.12 Aspire Pharma Ltd

13.12.1 Aspire Pharma Ltd Company Information

13.12.2 Aspire Pharma Ltd Eye Drops for Glaucoma Product Offered

13.12.3 Aspire Pharma Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Aspire Pharma Ltd Main Business Overview

13.12.5 Aspire Pharma Ltd Latest Developments

13.13 AbbVie Ltd

13.13.1 AbbVie Ltd Company Information

13.13.2 AbbVie Ltd Eye Drops for Glaucoma Product Offered

13.13.3 AbbVie Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 AbbVie Ltd Main Business Overview

13.13.5 AbbVie Ltd Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Eye Drops for Glaucoma Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Eye Drops for Glaucoma Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Bimatoprost

Table 4. Major Players of Latanoprost

Table 5. Major Players of Tafluprost

Table 6. Major Players of Travoprost

Table 7. Global Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)

Table 8. Global Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)

Table 9. Global Eye Drops for Glaucoma Revenue by Type (2017-2022) & ($ million)

Table 10. Global Eye Drops for Glaucoma Revenue Market Share by Type (2017-2022)

Table 11. Global Eye Drops for Glaucoma Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)

Table 13. Global Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)

Table 14. Global Eye Drops for Glaucoma Revenue by Application (2017-2022)

Table 15. Global Eye Drops for Glaucoma Revenue Market Share by Application (2017-2022)

Table 16. Global Eye Drops for Glaucoma Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Eye Drops for Glaucoma Sales by Company (2020-2022) & (K Units)

Table 18. Global Eye Drops for Glaucoma Sales Market Share by Company (2020-2022)

Table 19. Global Eye Drops for Glaucoma Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Eye Drops for Glaucoma Revenue Market Share by Company (2020-2022)

Table 21. Global Eye Drops for Glaucoma Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Eye Drops for Glaucoma Producing Area Distribution and Sales Area

Table 23. Players Eye Drops for Glaucoma Products Offered

Table 24. Eye Drops for Glaucoma Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Eye Drops for Glaucoma Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Eye Drops for Glaucoma Sales Market Share Geographic Region (2017-2022)

Table 29. Global Eye Drops for Glaucoma Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Eye Drops for Glaucoma Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Eye Drops for Glaucoma Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Eye Drops for Glaucoma Sales Market Share by Country/Region (2017-2022)

Table 33. Global Eye Drops for Glaucoma Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Eye Drops for Glaucoma Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)

Table 36. Americas Eye Drops for Glaucoma Sales Market Share by Country (2017-2022)

Table 37. Americas Eye Drops for Glaucoma Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Eye Drops for Glaucoma Revenue Market Share by Country (2017-2022)

Table 39. Americas Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)

Table 40. Americas Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)

Table 41. Americas Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)

Table 42. Americas Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)

Table 43. APAC Eye Drops for Glaucoma Sales by Region (2017-2022) & (K Units)

Table 44. APAC Eye Drops for Glaucoma Sales Market Share by Region (2017-2022)

Table 45. APAC Eye Drops for Glaucoma Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Eye Drops for Glaucoma Revenue Market Share by Region (2017-2022)

Table 47. APAC Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)

Table 48. APAC Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)

Table 49. APAC Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)

Table 50. APAC Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)

Table 51. Europe Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)

Table 52. Europe Eye Drops for Glaucoma Sales Market Share by Country (2017-2022)

Table 53. Europe Eye Drops for Glaucoma Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Eye Drops for Glaucoma Revenue Market Share by Country (2017-2022)

Table 55. Europe Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)

Table 56. Europe Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)

Table 57. Europe Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)

Table 58. Europe Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Eye Drops for Glaucoma Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Eye Drops for Glaucoma

Table 68. Key Market Challenges & Risks of Eye Drops for Glaucoma

Table 69. Key Industry Trends of Eye Drops for Glaucoma

Table 70. Eye Drops for Glaucoma Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Eye Drops for Glaucoma Distributors List

Table 73. Eye Drops for Glaucoma Customer List

Table 74. Global Eye Drops for Glaucoma Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Eye Drops for Glaucoma Sales Market Forecast by Region

Table 76. Global Eye Drops for Glaucoma Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Eye Drops for Glaucoma Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Eye Drops for Glaucoma Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Eye Drops for Glaucoma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Eye Drops for Glaucoma Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Eye Drops for Glaucoma Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Eye Drops for Glaucoma Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Eye Drops for Glaucoma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Eye Drops for Glaucoma Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Eye Drops for Glaucoma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Eye Drops for Glaucoma Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Eye Drops for Glaucoma Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Eye Drops for Glaucoma Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Eye Drops for Glaucoma Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Eye Drops for Glaucoma Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Eye Drops for Glaucoma Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Eye Drops for Glaucoma Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Eye Drops for Glaucoma Revenue Market Share Forecast by Application (2023-2028)

Table 94. Thea Pharmaceuticals Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 95. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product Offered

Table 96. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Thea Pharmaceuticals Ltd Main Business

Table 98. Thea Pharmaceuticals Ltd Latest Developments

Table 99. FDC International Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 100. FDC International Ltd Eye Drops for Glaucoma Product Offered

Table 101. FDC International Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. FDC International Ltd Main Business

Table 103. FDC International Ltd Latest Developments

Table 104. Martindale Pharma Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 105. Martindale Pharma Eye Drops for Glaucoma Product Offered

Table 106. Martindale Pharma Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Martindale Pharma Main Business

Table 108. Martindale Pharma Latest Developments

Table 109. Zentiva Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 110. Zentiva Eye Drops for Glaucoma Product Offered

Table 111. Zentiva Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Zentiva Main Business

Table 113. Zentiva Latest Developments

Table 114. Upjohn UK Limited Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 115. Upjohn UK Limited Eye Drops for Glaucoma Product Offered

Table 116. Upjohn UK Limited Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Upjohn UK Limited Main Business

Table 118. Upjohn UK Limited Latest Developments

Table 119. Beacon Pharmaceuticals Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 120. Beacon Pharmaceuticals Eye Drops for Glaucoma Product Offered

Table 121. Beacon Pharmaceuticals Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Beacon Pharmaceuticals Main Business

Table 123. Beacon Pharmaceuticals Latest Developments

Table 124. Novartis Pharmaceuticals UK Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 125. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product Offered

Table 126. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Novartis Pharmaceuticals UK Ltd Main Business

Table 128. Novartis Pharmaceuticals UK Ltd Latest Developments

Table 129. Mylan Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 130. Mylan Eye Drops for Glaucoma Product Offered

Table 131. Mylan Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Mylan Main Business

Table 133. Mylan Latest Developments

Table 134. Accord Healthcare Limited Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 135. Accord Healthcare Limited Eye Drops for Glaucoma Product Offered

Table 136. Accord Healthcare Limited Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Accord Healthcare Limited Main Business

Table 138. Accord Healthcare Limited Latest Developments

Table 139. Sandoz Limited Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 140. Sandoz Limited Eye Drops for Glaucoma Product Offered

Table 141. Sandoz Limited Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Sandoz Limited Main Business

Table 143. Sandoz Limited Latest Developments

Table 144. Thornton & Ross Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 145. Thornton & Ross Ltd Eye Drops for Glaucoma Product Offered

Table 146. Thornton & Ross Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Thornton & Ross Ltd Main Business

Table 148. Thornton & Ross Ltd Latest Developments

Table 149. Aspire Pharma Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 150. Aspire Pharma Ltd Eye Drops for Glaucoma Product Offered

Table 151. Aspire Pharma Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Aspire Pharma Ltd Main Business

Table 153. Aspire Pharma Ltd Latest Developments

Table 154. AbbVie Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors

Table 155. AbbVie Ltd Eye Drops for Glaucoma Product Offered

Table 156. AbbVie Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. AbbVie Ltd Main Business

Table 158. AbbVie Ltd Latest Developments

List of Figures

Figure 1. Picture of Eye Drops for Glaucoma

Figure 2. Eye Drops for Glaucoma Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Eye Drops for Glaucoma Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Eye Drops for Glaucoma Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Eye Drops for Glaucoma Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Bimatoprost

Figure 10. Product Picture of Latanoprost

Figure 11. Product Picture of Tafluprost

Figure 12. Product Picture of Travoprost

Figure 13. Global Eye Drops for Glaucoma Sales Market Share by Type in 2021

Figure 14. Global Eye Drops for Glaucoma Revenue Market Share by Type (2017-2022)

Figure 15. Eye Drops for Glaucoma Consumed in Hospital

Figure 16. Global Eye Drops for Glaucoma Market: Hospital (2017-2022) & (K Units)

Figure 17. Eye Drops for Glaucoma Consumed in Ophthalmic Clinic

Figure 18. Global Eye Drops for Glaucoma Market: Ophthalmic Clinic (2017-2022) & (K Units)

Figure 19. Eye Drops for Glaucoma Consumed in Pharmacy

Figure 20. Global Eye Drops for Glaucoma Market: Pharmacy (2017-2022) & (K Units)

Figure 21. Eye Drops for Glaucoma Consumed in Others

Figure 22. Global Eye Drops for Glaucoma Market: Others (2017-2022) & (K Units)

Figure 23. Global Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)

Figure 24. Global Eye Drops for Glaucoma Revenue Market Share by Application in 2021

Figure 25. Eye Drops for Glaucoma Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Eye Drops for Glaucoma Revenue Market Share by Company in 2021

Figure 27. Global Eye Drops for Glaucoma Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Eye Drops for Glaucoma Revenue Market Share by Geographic Region in 2021

Figure 29. Global Eye Drops for Glaucoma Sales Market Share by Region (2017-2022)

Figure 30. Global Eye Drops for Glaucoma Revenue Market Share by Country/Region in 2021

Figure 31. Americas Eye Drops for Glaucoma Sales 2017-2022 (K Units)

Figure 32. Americas Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)

Figure 33. APAC Eye Drops for Glaucoma Sales 2017-2022 (K Units)

Figure 34. APAC Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)

Figure 35. Europe Eye Drops for Glaucoma Sales 2017-2022 (K Units)

Figure 36. Europe Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Eye Drops for Glaucoma Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)

Figure 39. Americas Eye Drops for Glaucoma Sales Market Share by Country in 2021

Figure 40. Americas Eye Drops for Glaucoma Revenue Market Share by Country in 2021

Figure 41. United States Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Eye Drops for Glaucoma Sales Market Share by Region in 2021

Figure 46. APAC Eye Drops for Glaucoma Revenue Market Share by Regions in 2021

Figure 47. China Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Eye Drops for Glaucoma Sales Market Share by Country in 2021

Figure 54. Europe Eye Drops for Glaucoma Revenue Market Share by Country in 2021

Figure 55. Germany Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Eye Drops for Glaucoma Revenue Market Share by Country in 2021

Figure 62. Egypt Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Eye Drops for Glaucoma in 2021

Figure 68. Manufacturing Process Analysis of Eye Drops for Glaucoma

Figure 69. Industry Chain Structure of Eye Drops for Glaucoma

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390